Breaking down cancer cells to build a better vaccine? 🧫🧬 We previously found a clever way to improve personalized cancer immunotherapies. Traditionally, scientists use "tumor lysate" (broken down cancer cells) to teach the immune system what to fight. The problem? Lysate doesn't always trigger a strong immune response. Enter "Reduced Cancer Cells" (RCCs). In this study, we mechanically disrupted cancer cells into tiny, membrane-enclosed vesicles. Because they are packaged l

An animation to accompany our "Modular biomaterials vaccine technology protects against multiple pathogens and septic shock" paper, where we describe the development of ciVAX (Composite Infection Vaccine), a modular, injectable biomaterial scaffold designed to provide broad-spectrum protection against lethal bacterial infections and sepsis. Full report @ https://is.gd/CzSnuk #sepsis #vaccines #Biomaterials #medtech #science #publichealth #pathogenX #pandemics

Our "Modular biomaterials vaccine technology protects against multiple pathogens and septic shock" paper describes the development of ciVAX (Composite Infection Vaccine), a modular, injectable biomaterial scaffold designed to provide broad-spectrum protection against lethal bacterial infections and sepsis. Full report @ https://is.gd/CzSnuk #sepsis #vaccines #Biomaterials #medtech #science #publichealth #pathogenX #pandemics Core Technology: How ciVAX Works The vaccine is no